The Pharmaceutical Materials and Dosage Form Design array seeks to accommodate a accurate base for the development of bigger dosage forms. Physicochemical characterisation of new drugs and excipients and the conception of atypical biologic supply systems to accomplish optimised bioavailability, biologic targeting and ameliorative outcomes are the capital objectives of this cluster. Formulations are developed for all the capital routes of administering (including oral, nail, pulmonary, parenteral) and a amount of proprietary biologic supply platforms accept been progressed to the point of commercially availability (such as microparticles, nano-particles and enteric polymer blanket systems). There are particular interests in the challenges of developing medicines for paediatric and aged patients and in developing personalised dosage delivery systems.
